| 20-HETE | 20-hydroxyeicosatetraenoic acid |
| Ado | Adenosine |
| AGE–RAGE | Advanced glycation end-product-receptor for AGE |
| AQP4 | Aquaporin-4 |
| ATP | Adenosine triphosphate |
| BRB | Blood–retinal barrier |
| cGMP | Cyclic guanosine monophosphate |
| CO2 | Carbon dioxide |
| COX | Cyclooxygenase |
| COX-2 | Cyclooxygenase-2 |
| Cx43 | Connexin43 |
| DR | Diabetic retinopathy |
| DVA | Dynamic vessel analysis |
| EET | Epoxyeicosatrienoic acid |
| EETs | Epoxyeicosatrienoic acids |
| eNOS | Endothelial nitric oxide synthase |
| fOCTA | Functional optical coherence tomography angiography |
| GCL | Ganglion cell layer |
| HbA1c | Glycated hemoglobin (hemoglobin a1c) |
| HIF | Hypoxia-inducible factor |
| HIF-1α | Hypoxia-inducible factor-1α |
| HRV | Heart rate variability |
| ICAM-1 | Intercellular adhesion molecule-1 |
| IL-1β | Interleukin-1 beta |
| INL | Inner nuclear layer |
| IOP | Intraocular pressure |
| iNOS | Inducible nitric oxide synthase |
| Kir4.1 | Inwardly rectifying potassium channel 4.1 |
| NE | Norepinephrine |
| NE/Epi | Norepinephrine/epinephrine |
| NLRP3 | NLR-family pyrin domain-containing 3 |
| NO | Nitric oxide |
| nNOS | Neuronal nitric oxide synthase |
| NVC | Neurovascular coupling |
| NVU | Neurovascular unit |
| OCT | Optical coherence tomography |
| OCTA | Optical coherence tomography angiography |
| ONL | Outer nuclear layer |
| OSA | Obstructive sleep apnea |
| PaCO2 | Arterial partial pressure of carbon dioxide |
| PEEP | Positive end-expiratory pressure |
| PGE2 | Prostaglandin E2 |
| PKC | Protein kinase C |
| ROS | Reactive oxygen species |
| RPE | Retinal pigment epithelium |
| sGC | Soluble guanylate cyclase |
| TEER | Transepithelial electrical resistance |
| TNF-α | Tumor necrosis factor-alpha |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VEGF | Vascular endothelial growth factor |
| ZO-1 | Zonula occludens-1 |
| α1 | A1-adrenergic receptor |
| α1B | A1B-adrenergic receptor |
| β2AR | Β2-adrenergic receptor |